Literature DB >> 21692064

Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia risk.

Li-Chung Chuang1, Chung-Yi Hu, Hui-Chi Chen, Pei-Jung Lin, Borheng Lee, Ching-Yu Lin, Mei-Hung Pan, San-Lin You, Chang-Yao Hsieh, Chien-Jen Chen.   

Abstract

BACKGROUND: Only a small proportion of women infected with human papillomavirus type 18 (HPV18) may progress to persistent infection and cervical neoplasia. This community-based cohort study aimed to assess associations with human leukocyte antigen (HLA) class II genotypes for natural infection of HPV18 and subsequent risk of cervical neoplasia.
METHODS: Among 10,190 cytologically normal participants, 125 with HPV18 infection were identified by HPV blot kit. HPV18 viral load at study entry was examined by real-time polymerase chain reaction; persistent infection was defined as HPV18 infection at 2 consecutive examinations.
RESULTS: There was a significant association between HLA-DRB1*0403 allele and high HPV18 viral load (>1000 copies in 50 ng of total DNA) at study entry (odds ratio [OR], 7.2; 95% confidence interval [CI], 2.0-25.2). After adjustment for age and viral load at study entry, haplotype HLA-DRB1*0405-DQA1*0301-DQB1*0302 was significantly associated with persistent HPV18 infection (OR, 13.3; 95% CI, 1.7-105.9). HLA-DRB1*0403 allele was also associated with a significantly increased risk of high-grade squamous intraepithelial lesion or cancer, showing a multivariate-adjusted hazard ratio (95% CI) of 18.1 (2.6-128.5).
CONCLUSIONS: HLA-DRB1*0403 allele and HLA-DRB1*0405-DQA1*0301-DQB1*0302 haplotype may play important roles in determination of high viral load and persistent infection of HPV18 and subsequent cervical neoplasia risk.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692064     DOI: 10.1002/cncr.26227

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomas.

Authors:  Quan Zhou; Jin Xu; Jiali Zhao; Shaoxian Zhang; Wei Pan
Journal:  Onco Targets Ther       Date:  2014-03-24       Impact factor: 4.147

2.  Identifying the HLA DRB1-DQB1 molecules and predicting epitopes associated with high-risk HPV infection clearance and redetection.

Authors:  Luisa Del Río-Ospina; Milena Camargo; Sara C Soto-De León; Ricardo Sánchez; Darwin A Moreno-Pérez; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

3.  Association Between BoLA-DRB3.2 Polymorphism and Bovine Papillomavirus Infection for Bladder Tumor Risk in Podolica Cattle.

Authors:  Maria Longeri; Valeria Russo; Maria Giuseppina Strillacci; Antonella Perillo; Michela Carisetti; Maria Cristina Cozzi; Benedetto Neola; Sante Roperto
Journal:  Front Vet Sci       Date:  2021-06-09

4.  The association of DNA Repair with breast cancer risk in women. A comparative observational study.

Authors:  Jaime Matta; Miguel Echenique; Esperanza Negron; Luisa Morales; Wanda Vargas; Felipe Sánchez Gaetan; Eduardo Ramírez Lizardi; Aníbal Torres; Jose Ortiz Rosado; Guillermo Bolaños; Juan González Cruz; Joaquín Laboy; Ricardo Barnes; Santos Santiago Medina; Angel Romero; Rosendo Martinez; Julie Dutil; Erick Suarez; Carolina Alvarez-Garriga; Manuel Bayona
Journal:  BMC Cancer       Date:  2012-10-22       Impact factor: 4.430

5.  Simultaneous detection and differentiation of human papillomavirus genotypes 6, 11, 16 and 18 by AllGlo quadruplex quantitative PCR.

Authors:  Daojun Yu; Yu Chen; Shenghai Wu; Baohong Wang; Yi-Wei Tang; Lanjuan Li
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

6.  The association of the immune response genes to human papillomavirus-related cervical disease in a Brazilian population.

Authors:  Amanda Vansan Marangon; Gláucia Andreia Soares Guelsin; Jeane Eliete Laguila Visentainer; Sueli Donizete Borelli; Maria Angélica Ehara Watanabe; Márcia Edilaine Lopes Consolaro; Katiany Rizzieri Caleffi-Ferracioli; Cristiane Conceição Chagas Rudnick; Ana Maria Sell
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

7.  Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.

Authors:  Larissa Bahls; Roger Yamakawa; Karina Zanão; Daniela Alfieri; Tamires Flauzino; Francieli Delongui; André de Abreu; Raquel Souza; Fabrícia Gimenes; Edna Reiche; Sueli Borelli; Marcia Consolaro
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.